Previous Close | 10.07 |
Open | 10.03 |
Bid | 10.10 x 800 |
Ask | 16.03 x 900 |
Day's Range | 9.87 - 10.11 |
52 Week Range | 7.80 - 16.76 |
Volume | |
Avg. Volume | 436,101 |
Market Cap | 748.077M |
Beta (5Y Monthly) | N/A |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.10 |
Earnings Date | Mar 07, 2023 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 12.30 |
Shares of financial-services software company Enfusion (NYSE: ENFN) surged on Tuesday after the company released financial results for the fourth quarter of 2022. As of noon ET, Enfusion stock was up almost 10%. During Q4, Enfusion generated revenue of $40.5 million, which was up more than 27% from the same quarter of 2021.
Enfusion, Inc. (ENFN) delivered earnings and revenue surprises of 0% and 1.60%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?